EU’s IMI Pursues New Drug Development Tools, More Exclusivity

Drug Industry Daily
A A
A European public-private partnership is launching a new $4.5 billion decade-long effort to improve the success rate of clinical trials on certain drugs by 30 percent and boost exclusivity to make manufacturing treatments more enticing.

To View This Article:

Login

Subscribe To Drug Industry Daily